About: Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $5.41 (+5.66%)
DERM NASDAQ Journey Medical Corp
Journey Medical Corp share price
Atividade de preço de DERM
Último preço
$ 5,410
Variação (24h)
0,29 USD (5,66%)
Volume
206.68K
Volume (média 4 sem.)
-
Abertura
$ 5,20
Variação do dia
$ 5,15 - $ 5,48
Fechamento anterior
$ 5,12
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
DERM price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals